Immunosenescence
19
6
7
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 19 trials
100.0%
+13.5% vs benchmark
5%
1 trials in Phase 3/4
14%
1 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (19)
Interferon Reference for Older People - REFIPA Study
Skin Inflammation in Perimenopause: A Probiotic Intervention Proof of Concept Trial
The Impact of Aerobic Exercise Program on Immunosenescence Institutionalized Older Adults
Precision Microbiota Interventions for Senoreduction Trial
Effect of Oral Supplement on Influenza Vaccine Long-term Response
VITAL: Vaccination, Immunity, Time-restricted Eating, Aging and Lifestyle
Biobank and Brain Health in Bordeaux.
The Impact of Nicotinamide Mononucleotide Sustained-release Tablets on Immunosenescence and Metablism in Middle-aged and Elderly Individuals With Metabolic Disorders.
Thymus Regeneration, Immunorestoration, and Insulin Mitigation Extension Trial
The Immu-KNEE-ty Study
Using BCG to Protect Senior Citizens During the COVID-19 Pandemic
COVID-19 Serology and Immunosenescence
Vitamin D Supplementation And Varicella Zoster Virus Vaccine Responsiveness In Older Long-Term Care Residents
Pyridostigmine as Immunomodulator in People Living With HIV
Fasting-mimicking Diet and Immunosenescence
Effect of Milk Protein and Prebiotics in Combination With Vitamin D on Innate Immunity in Elderly People
Pilot Study on Effect Size of Non-digestible Polysaccharides (NPS) on Immunity
The Effect of Prebiotic B-GOS on the Immune Function, Metabolism and Gut Microbiota of Elderly People
Nutritional Supplementation and Muscle Health: A Pilot Study on Immune Function